✦ LIBER ✦

Globin gene transfer as a potential treatment for the β-thalassaemias and sickle cell disease

✍ Scribed by M. Sadelain

Book ID: 111307533
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 137 KB
Volume: 87
Category: Article
ISSN: 0042-9007
DOI: 10.1111/j.1741-6892.2004.00495.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Globin gene transfer for treatment of th

Globin gene transfer for treatment of the β-thalassemias and sickle cell disease

✍ Michel Sadelain; Stefano Rivella; Leszek Lisowski; Selda Samakoglu; Isabelle Riv 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Gene Transfer : A Potential Approach to

Gene Transfer : A Potential Approach to Gene Therapy for Sickle Cell Disease

✍ ARTHUR BANK; DINA MARKOWITZ; NORMA LERNER 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB

Sickle cell disease due to compound hete

Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb β-globin gene deletion

✍ B. Anders R. Andersson; Mikaela E. L. Wering; Hong-Yuan Luo; Raveen K. Basran; M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

β-Globin gene cluster haplotypes and HbF

β-Globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon

✍ A. Inati; A. Taher; W. Bou Alawi W; S. Koussa; H. Kaspar; H. Shbaklo; P. A. Zall 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Globin gene transfer for the treatment o

Globin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for stem cell-based gene therapy

✍ Michel Sadelain 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

## Abstract The prospect of treating blood disorders with genetically modified stem cells is highly promising. This therapeutic approach, however, raises a number of fundamental biological questions, spanning several research fields. Further investigation is required to better understand how to iso

Feasibility and benefit of hydroxycarbam

Feasibility and benefit of hydroxycarbamide as a long-term treatment for sickle cell disease patients: Results from the North West London Sickle Cell Disease Registry

✍ Annette Gilmore; Gavin Cho; Jo Howard; Mark Layton; Michele Afif; Robert George 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB